Celsius Therapeutics Company

Celsius Therapeutics is a biotechnology company that develops precision medicines for cancer and autoimmune disease patients.
Technology: Biotechnology, Emergency Medicine, Genetics, Health Care
Industry: Early Drug Development
Headquarters: Cambridge, Massachusetts, United States
Founded Date: 2018-01-01
Employees Number: 11-50
Funding Status: Early Stage Venture
Investors Number: 11
Total Funding: 148000000
Estimated Revenue: $1M to $10M
Last Funding Date: 2022-03-24
Last Funding Type: Series B

Visit Website
Register and Claim Ownership